Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients

Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients

Abstract Tyrosine kinase inhibitors (TKIs), VEGF/VEGF receptor inhibitors (VEGFIs) and immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced cancers including non-small-cell lung cancer (NSCLC). This study aims to evaluate the utility of plasma cell-free DNA (cfDNA) as a...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaorong Zhou, Chenchen Li, Zhao Zhang, Daniel Y. Li, Jinwei Du, Ping Ding, Haiyan Meng, Hui Xu, Ronglei Li, Effie Ho, Aiguo Zhang, Paul Okunieff, Jianwei Lu, Michael Y. Sha
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/b2343cf2b10446a4ab9c404bea005c66
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/b2343cf2b10446a4ab9c404bea005c66

Similar Items